Recap: Aerie Pharmaceuticals Q4 Earnings

Aerie Pharmaceuticals AERI reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Aerie Pharmaceuticals beat estimated earnings by 262.69%, reporting an EPS of $1.09 versus an estimate of $-0.67.

Revenue was up $89.98 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 1.92% increase in the share price the next day.

Here's a look at Aerie Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.